For Pharma
Not the drug. Every failed trial died the same death: the right patient, found too late. DeepSensi™ eliminates the need for massive, slow-to-recruit placebo groups via Synthetic Control Arms (SCA), and matches the perfect trial candidate at the exact moment their physician runs the differential diagnosis. Recruitment begins before the patient even leaves the clinic.
What changes
The reason 90% of trials fail is the denominator: the right patient is found months too late. DeepSensi identifies the perfect trial candidate at the exact moment their physician runs the differential diagnosis, spanning four continents simultaneously.
DeepSensi leverages the temporal health graphs of millions of validated, structured patient journeys to construct Synthetic Control Arms (SCA) with mathematical precision. Phase II/III trials accelerate by months.
Standard EHR sweeps give you noisy, unstructured text. DeepSensi provides data that has already been reasoned through and verified by the Hyper Consilium. You are buying verified clinical intelligence.
A distributed architecture with global reach.
Live ingestion from 46 scientific databases keeps your compound’s evidence base current inside every deliberation.
Hospitals exchange validated diagnostic patterns, not records: privacy-preserving signals across borders and jurisdictions.